AU2022424476A1 - Temperature-sensitive negative-strand RNA virus or virus vector and RNA genome thereof - Google Patents

Temperature-sensitive negative-strand RNA virus or virus vector and RNA genome thereof Download PDF

Info

Publication number
AU2022424476A1
AU2022424476A1 AU2022424476A AU2022424476A AU2022424476A1 AU 2022424476 A1 AU2022424476 A1 AU 2022424476A1 AU 2022424476 A AU2022424476 A AU 2022424476A AU 2022424476 A AU2022424476 A AU 2022424476A AU 2022424476 A1 AU2022424476 A1 AU 2022424476A1
Authority
AU
Australia
Prior art keywords
virus
protein
amino acid
cell
negative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022424476A
Other languages
English (en)
Inventor
Koichi Saeki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Repli Tech Co Ltd
Original Assignee
Repli Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repli Tech Co Ltd filed Critical Repli Tech Co Ltd
Publication of AU2022424476A1 publication Critical patent/AU2022424476A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18811Sendai virus
    • C12N2760/18821Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18811Sendai virus
    • C12N2760/18822New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18811Sendai virus
    • C12N2760/18841Use of virus, viral particle or viral elements as a vector
    • C12N2760/18843Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2022424476A 2021-12-27 2022-12-27 Temperature-sensitive negative-strand RNA virus or virus vector and RNA genome thereof Pending AU2022424476A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021-213114 2021-12-27
JP2021213114 2021-12-27
PCT/JP2022/048141 WO2023127871A1 (ja) 2021-12-27 2022-12-27 温度感受性のマイナス鎖rnaウイルスまたはウイルスベクターおよびそのrnaゲノム

Publications (1)

Publication Number Publication Date
AU2022424476A1 true AU2022424476A1 (en) 2024-07-11

Family

ID=86998996

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022424476A Pending AU2022424476A1 (en) 2021-12-27 2022-12-27 Temperature-sensitive negative-strand RNA virus or virus vector and RNA genome thereof

Country Status (7)

Country Link
US (1) US20250333760A1 (https=)
EP (1) EP4458974A1 (https=)
JP (2) JPWO2023127871A1 (https=)
CN (1) CN118475700A (https=)
AU (1) AU2022424476A1 (https=)
CA (1) CA3243062A1 (https=)
WO (1) WO2023127871A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2024195811A1 (https=) * 2023-03-22 2024-09-26
WO2025033445A1 (ja) 2023-08-07 2025-02-13 株式会社Logomix 遺伝子をコンディショナルに不活化させる方法、およびそのための細胞

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4206154B2 (ja) 1997-11-13 2009-01-07 大日本住友製薬株式会社 変異型loxP配列とその応用
JP4787440B2 (ja) 1999-09-30 2011-10-05 泉 斎藤 変異型frt配列を含有してなるdna
JPWO2003025570A1 (ja) * 2001-09-18 2004-12-24 株式会社ディナベック研究所 粒子形成能が低下した(−)鎖rnaウィルスベクターの検査方法および製造方法
JP4999330B2 (ja) 2004-01-22 2012-08-15 株式会社ディナベック研究所 サイトメガロウイルスエンハンサーおよびニワトリβ−アクチンプロモーターを含むハイブリッドプロモーターを利用したマイナス鎖RNAウイルスベクターの製造方法
JPWO2005071085A1 (ja) 2004-01-22 2007-09-06 株式会社ディナベック研究所 ウイルスベクターの製造方法
JP2006180780A (ja) * 2004-12-27 2006-07-13 National Institute Of Advanced Industrial & Technology 持続感染型センダイウイルスベクター
US8173792B2 (en) 2007-02-09 2012-05-08 The Board Of Trustees Of The Leland Stanford Junior University Method for regulating protein function in cells using synthetic small molecules
US8530636B2 (en) * 2008-05-07 2013-09-10 The Board Of Trustees Of The Leland Stanford Junior University Method for regulating protein function in cells in vivo using synthetic small molecules
US9127256B2 (en) * 2008-07-16 2015-09-08 Dnavec Corporation Method for production of reprogrammed cell using chromosomally unintegrated virus vector
CA2809515A1 (en) 2010-08-30 2012-03-08 Dnavec Corporation Composition for inducing pluripotent stem cell, and use thereof
WO2017082174A1 (ja) * 2015-11-13 2017-05-18 株式会社Idファーマ 改良されたパラミクソウイルスベクター

Also Published As

Publication number Publication date
JPWO2023127871A1 (https=) 2023-07-06
EP4458974A1 (en) 2024-11-06
CN118475700A (zh) 2024-08-09
JP2025081483A (ja) 2025-05-27
US20250333760A1 (en) 2025-10-30
WO2023127871A1 (ja) 2023-07-06
CA3243062A1 (en) 2025-04-16

Similar Documents

Publication Publication Date Title
ES2726766T3 (es) Método para el desarrollo eficiente de células madre pluripotentes inducidas
AU2022424476A1 (en) Temperature-sensitive negative-strand RNA virus or virus vector and RNA genome thereof
CN102159710B (zh) 使用染色体非整合型病毒载体制造经初始化的细胞的方法
WO2021050593A1 (en) Compositions and methods for the targeting of sod1
EP4121535A1 (en) Compositions and methods for the targeting of c9orf72
JP2019122398A (ja) ヒト細胞を若返らせるためのzscan4の使用方法
US20150184131A1 (en) Enhanced Efficiency of Induced Pluripotent Stem Cell Generation
JPWO2016125364A1 (ja) 改良されたマイナス鎖rnaウイルスベクター
JP6927883B2 (ja) 改良されたパラミクソウイルスベクター
CN101646768A (zh) 减毒负链rna病毒
Warren et al. Feeder‐free reprogramming of human fibroblasts with messenger RNA
HK40117834A (en) Temperature-sensitive minus-strand rna virus or virus vector and rna genome thereof
EP4685236A1 (en) Temperature-sensitive negative-strand rna virus or viral vector and rna genome thereof
JPWO2017209290A1 (ja) 多能性幹細胞由来運動ニューロンの製造及びその用途
EP3518941B1 (en) Viral vectors for nuclear reprogramming
WO2016056438A1 (ja) 心筋様細胞の作製方法及びそれに用いる心筋様細胞の作製用組成物
JP7808298B2 (ja) iPS細胞の品質改善剤、iPS細胞の製造方法、iPS細胞、及びiPS細胞製造用組成物
JP2004344001A (ja) 胚性幹細胞に遺伝子を導入する方法
HK40080409A (en) Viral vectors for nuclear reprogramming
WO2019017438A1 (ja) 標的配列を改変するためのポリヌクレオチドおよびその使用